Monashee Investment Management slashed its stake in Structure Therapeutics by $13.24 million, a move raising questions about the biotech firm's future. Is this a red flag for investors, or just a strategic play?
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026
Jun 26, 2026